NCT05285748

Brief Summary

We will randomly assign (blocked on Gender (female, male, other), body mass index (BMI; overweight \[25 \< BMI \< 30\]) or obese (30 \< BMI \<40) and pain status (chronic pain vs not)) adults ages 50-64 into either; (a) self-selected intensity (i.e., SELF-PACED) or (b) prescribed moderate intensity (i.e., PRESCRIBED) conditions. Prior to randomization, persons responding to our ads will participate in the following: (1) telephone screening with the study research assistant (RA) to establish eligibility; (2) an orientation session to obtain more information about the study; and, after providing informed consent (3) baseline assessment and screening (bodyweight, maximal fitness test, dietary intake, and questionnaires to assess potential covariates). Prior to randomization, the RA will give participants an accelerometer to assess baseline physical activity (PA) behavior over a one-week period. Participants will then be randomized to one of the two study conditions. Following randomization, all participants will receive our theory-based PA promotion intervention to help them overcome barriers to regular PA. All participants will be given chest strap heart rate (HR) monitors and instructions on wrist palpation. Follow-up assessments will consist of accelerometry for one-week periods at months 3, 6, 9, and 12, ecological momentary assessment (EMA) throughout the 12 months and bodyweight at 3-month intervals.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
258

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2022

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2022

Completed
20 days until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 18, 2022

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

4.1 years

First QC Date

February 23, 2022

Last Update Submit

May 28, 2025

Conditions

Keywords

Physical activityExerciseSelf-pacing

Outcome Measures

Primary Outcomes (2)

  • Change in total volume of structured PA

    Minutes of PA weighted by intensity, expressed in metabolic equivalent (MET) minutes as determined by accelerometers (Actigraph \[model wGT3x-BT\]) worn during one-week periods.

    Measured at baseline, and months 3, 6, 9, and 12.

  • Minutes per week of PA

    Participants will be instructed to indicate, in real time, each time they begin and end a PA session via EMA.

    Measured daily from date of randomization for 52 weeks based on participant initiation of exercise

Secondary Outcomes (1)

  • Changes in Body Weight

    Measured at baseline, and months 3, 6, 9, and 12.

Other Outcomes (23)

  • Opportunity Questionnaire

    Measured at baseline, and months 3, 6, 9, and 12.

  • Capability Questionnaire

    Measured at baseline, and months 3, 6, 9, and 12.

  • Exercise Motivation Questionnaire

    Measured at baseline, and months 3, 6, 9, and 12.

  • +20 more other outcomes

Study Arms (2)

Self-Paced Intensity Physical Activity

EXPERIMENTAL
Behavioral: Self-Paced Intensity Physical Activity

Prescribed Moderate Intensity Physical Activity

ACTIVE COMPARATOR
Behavioral: Prescribed Moderate Intensity Physical Activity

Interventions

Participants are given a prescription to engage in 150-300 minutes per week of structured exercise with an emphasis on walking. For this study arm, participants are given the explicit recommendation to engage in self-selected intensity PA.

Self-Paced Intensity Physical Activity

Participants are given a prescription to engage in 150-300 minutes per week of structured exercise with an emphasis on walking. For this study arm, participants are given the explicit recommendation to engage in moderate intensity PA consistent with national guidelines.

Prescribed Moderate Intensity Physical Activity

Eligibility Criteria

Age50 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ages 50-64
  • BMI 25-40
  • Sedentary or low-active, defined as participating in \< 60 min/week of structured exercise
  • Has a smart phone that can connect to the internet at least once every few days and is compatible with smartphone app

You may not qualify if:

  • Past 3-month overnight hospitalization
  • Past 3-month treatment for heart disease, including bypass or valve surgery, interventional procedure(s) such as angioplasty (stent), or a pacemaker or other implanted device to control your heart rate or rhythm
  • Past 3-month inability to walk without assistance due to stroke, transient ischemic attack (TIA), or neurologic or spinal injury
  • Past 6-month angina, chest pain, or chest discomfort either at rest or with exertion/activity
  • Past 6-month peripheral vascular disease such as claudication which causes pain in the legs when walking briskly
  • Past 6-month seizure
  • Past 6-month overnight hospitalization due to respiratory disease
  • Past 6-month lightheadedness, vertigo, dizziness, or fainting
  • Heart, lung, abdominal, joint, or orthopedic surgeries in the past 12-months, or pending or scheduled in the next 12 months
  • Takes insulin and/or medication that affects the secretion of insulin
  • Exercise-induced asthma that prevents brisk walking
  • Takes anticonvulsant medication or medication to treat/control seizures
  • Diagnosed with cystic fibrosis
  • Bone or joint problems that make you unable to walk for at least 30 minutes
  • Physician has said not to exercise because of bone or joint problems
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brown University

Providence, Rhode Island, 02912, United States

Location

MeSH Terms

Conditions

Sedentary BehaviorMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • David M Williams, Ph.D.

    Brown University School of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 23, 2022

First Posted

March 18, 2022

Study Start

March 15, 2022

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

May 29, 2025

Record last verified: 2025-05

Locations